Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.
暂无分享,去创建一个
Ming-Ta Hsu | Y. Shann | M. Hsu | Dow-Tien Chen | Dow-Tien Chen | Yih-Jyh Shann | Ching Cheng | Chun-Hui Chiao | Pei-Hsin Li | Ching-wen Cheng | Chun-Hui Chiao | Peirui Li | Yih-Jyh Shann
[1] A. Hagemeijer,et al. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma , 2001, Leukemia.
[2] M. Esteller. Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.
[3] Y. Natkunam,et al. A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia. , 2001, Cancer genetics and cytogenetics.
[4] P. Pevzner,et al. Dynamics of Mammalian Chromosome Evolution Inferred from Multispecies Comparative Maps , 2005, Science.
[5] S. Henikoff. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. , 1984, Gene.
[6] E. Whitelaw,et al. How lifetimes shape epigenotype within and across generations. , 2006, Human molecular genetics.
[7] N. Carter,et al. Genomic Profiling Identifies Discrete Deletions Associated with Translocations in Glioblastoma Multiforme , 2006, Cell cycle.
[8] E. Lander,et al. The Mammalian Epigenome , 2007, Cell.
[9] U. Storb,et al. Hypomethylation is necessary but not sufficient for V(D)J recombination within a transgenic substrate. , 1999, Molecular Immunology.
[10] C. Walsh,et al. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation , 1998, Nature Genetics.
[11] B. Maraj,et al. Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene , 1999, Prostate Cancer and Prostatic Diseases.
[12] M. Groudine,et al. An Unmethylated 3′ Promoter-Proximal Region Is Required for Efficient Transcription Initiation , 2007, PLoS genetics.
[13] R. Ravazzolo,et al. Molecular characterization of a t(2;6) balanced translocation that is associated with a complex phenotype and leads to truncation of the TCBA1 gene , 2005, Human mutation.
[14] A. Zijlstra,et al. The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel. , 2006, Cancer cell.
[15] G. Hortobagyi,et al. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model , 2006, Molecular Cancer Therapeutics.
[16] E. Schoenmakers,et al. Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML , 2006, Leukemia.
[17] E. Zackai,et al. Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. , 2007, American journal of human genetics.
[18] J. Rogers,et al. DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.
[19] W. Coleman,et al. Identification of candidate liver tumor suppressor genes from human 11p11.2‐p12 , 2002, Genes, chromosomes & cancer.
[20] S. Hunger,et al. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia , 2005, Leukemia.
[21] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[22] K D Robertson,et al. DNA methylation: past, present and future directions. , 2000, Carcinogenesis.
[23] A. Bird. DNA Methylation de Novo , 1999, Science.
[24] N. Saitou,et al. Nucleotide sequence comparison of a chromosome rearrangement on human chromosome 12 and the corresponding ape chromosomes , 2004, Cytogenetic and Genome Research.
[25] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[26] C. Moskaluk,et al. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma , 2005, Laboratory Investigation.
[27] Chuan-ju Liu,et al. IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells. , 2007, Frontiers in bioscience : a journal and virtual library.
[28] P. Molloy,et al. DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.
[29] Jonathan E. Dodge,et al. Inactivation of Dnmt3b in Mouse Embryonic Fibroblasts Results in DNA Hypomethylation, Chromosomal Instability, and Spontaneous Immortalization* , 2005, Journal of Biological Chemistry.
[30] T. Bestor,et al. Epigenetic Decisions in Mammalian Germ Cells , 2007, Science.
[31] D. Birnbaum,et al. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line. , 2000, International journal of oncology.
[32] D. Pinkel,et al. Regional copy number–independent deregulation of transcription in cancer , 2006, Nature Genetics.
[33] Jose Castresana,et al. Is mammalian chromosomal evolution driven by regions of genome fragility? , 2006, Genome Biology.
[34] Peter A. Jones,et al. Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.
[35] Junjun Zhang,et al. Human Chromosome 7: DNA Sequence and Biology , 2003, Science.
[36] R. Hromas,et al. Fusion of AML1/Runx1 to Copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation , 2003, Leukemia.
[37] K. Hunt,et al. Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer , 2004, Oncogene.
[38] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[39] Hélène Hayes,et al. High-resolution comparative mapping among man, cattle and mouse suggests a role for repeat sequences in mammalian genome evolution , 2006, BMC Genomics.